US Patent Issued to Regeneron Pharmaceuticals on Sept. 15 for "Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,752, issued on Sept. 15, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof" was invented by Jack Kosmicki (Tarrytown, N.Y.), Julie Horowitz (Tarrytown, N.Y.), Manuel Allen Revez Ferreira (Tarrytown, N.Y.), Goncalo Abecasis (Tarrytown, N.Y.), Aris Baras (Tarrytown, N.Y.) and Amy Damask (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating subjects having a coronavirus infection, and methods of identifying subjects having an increased risk of a coronavirus infection are provided herein." ...